First Enterprise Sale in United States Medical Education
Filed with ASX · · 4 pages · English
Summary by 6ix AI
The contract spans two years and includes a significant number of both R&D and Patient licenses, aimed at enhancing medical education for students and patients at the university. This partnership marks a notable milestone as Roseman University becomes the first US college to adopt Singular's software as a medical education tool.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Singular Health Group Ltd on 6ix
Story so far
Earlier from Singular Health
- First 3Dicom Enterprise Sale Received in United States
- Enterprise Licence Order Received for 3Dicom R&D Software
- Singular Receives Commitment for $850,000 from CG1 Ventures
- Singular Receives R&D Tax Incentive Refund
- Appointment of Managing Director and Chief Executive Officer
Later from Singular Health
- CG1 Ventures Placement & R&D Advanced Funding
- Capital Raising
- Singular Retains ISO13485.2016 Certification
- Capital Raising Completion and Cleansing Statement
- Appendix 4D
Follow Singular Health into a list and get an email when it puts out news.
Follow Singular Health